Nurse Anesthetist - CR in Marshall, MN Accepting Medicare

7 Nurse Anesthetist - CR nurses found. Showing 1 - 7

Mr. Richard John Jueneman, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-537-9114    Fax: 507-537-9272

Mr. Daniel Thomas Offerdahl, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661

Jason D Klein, CRNA, MS Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1521 Carlson St, Marshall, MN 56258 Phone: 507-532-1901

Annie Marie Molseed, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661

Wendy A Vanderkooi, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-537-9114    Fax: 507-537-2757

Kaci Rainey, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661

Mr. Kevin Warren Peterson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661

News Archive

Powering up fat cells could help acute myeloid leukemia patients

Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Shionogi's naldemedine meets primary, secondary endpoints for treatment of opioid-induced constipation

Shionogi today announced that once-daily naldemedine met its primary and secondary endpoints in a phase III study (COMPOSE II) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

FDA provides draft guidance focusing on PMAs

For the first time, the U.S. Food and Drug Administration has provided draft guidance clarifying how benefit-risk determinations are made during premarket review of certain medical devices.

Psychological and social challenges faced by parents of children with undiagnosed learning disorders

Parents of children with undiagnosed learning disorders, developmental deficits, and congenital abnormalities face a host of psychological and social challenges, which are explored in detail in a reflective article in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).

Read more Medical News

› Verified 6 days ago